Cargando…

Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment

BACKGROUND: The prevalence of complementary and alternative medicine (CAM) use and the modalities used by pediatric oncology patients vary widely across studies. In addition, the changes in the use of CAM over the course of treatment are understudied. Thus, this study aimed to explore (1) CAM use by...

Descripción completa

Detalles Bibliográficos
Autores principales: Lüthi, Emmanuelle, Diezi, Manuel, Danon, Nadia, Dubois, Julie, Pasquier, Jérôme, Burnand, Bernard, Rodondi, Pierre-Yves
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977159/
https://www.ncbi.nlm.nih.gov/pubmed/33736643
http://dx.doi.org/10.1186/s12906-021-03271-9
_version_ 1783667084193955840
author Lüthi, Emmanuelle
Diezi, Manuel
Danon, Nadia
Dubois, Julie
Pasquier, Jérôme
Burnand, Bernard
Rodondi, Pierre-Yves
author_facet Lüthi, Emmanuelle
Diezi, Manuel
Danon, Nadia
Dubois, Julie
Pasquier, Jérôme
Burnand, Bernard
Rodondi, Pierre-Yves
author_sort Lüthi, Emmanuelle
collection PubMed
description BACKGROUND: The prevalence of complementary and alternative medicine (CAM) use and the modalities used by pediatric oncology patients vary widely across studies. In addition, the changes in the use of CAM over the course of treatment are understudied. Thus, this study aimed to explore (1) CAM use by pediatric oncology patients in relation to specific time intervals and (2) communication about CAM use between parents and oncologists. METHODS: This retrospective cross-sectional study was conducted among parents of children diagnosed with cancer at a Swiss pediatric hematology-oncology center by means of an online questionnaire. Questions were related to their child’s CAM use over different time intervals, sources of information about CAM use, and communication with the oncologists. RESULTS: Among 140 respondents, CAM was used by 54.3% of patients before diagnosis and 69.3% of patients after diagnosis. During each defined time interval, between 50 and 58.8% of the patients used at least one CAM. Homeopathy was the most popular CAM modality used during oncology treatment, during the first year after treatment, and between 1 and 5 years after the end of treatment. Osteopathy was the most popular CAM ≥5 years after the end of oncology treatment. Forty percent of respondents did not discuss CAM with their oncologist. CONCLUSIONS: The high prevalence of CAM use and the different trends of use during the oncology care pathway and afterward underline the need to increase communication about CAM in the pediatric oncology setting, notably regarding benefits and risks of interaction with oncology treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03271-9.
format Online
Article
Text
id pubmed-7977159
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79771592021-03-22 Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment Lüthi, Emmanuelle Diezi, Manuel Danon, Nadia Dubois, Julie Pasquier, Jérôme Burnand, Bernard Rodondi, Pierre-Yves BMC Complement Med Ther Research Article BACKGROUND: The prevalence of complementary and alternative medicine (CAM) use and the modalities used by pediatric oncology patients vary widely across studies. In addition, the changes in the use of CAM over the course of treatment are understudied. Thus, this study aimed to explore (1) CAM use by pediatric oncology patients in relation to specific time intervals and (2) communication about CAM use between parents and oncologists. METHODS: This retrospective cross-sectional study was conducted among parents of children diagnosed with cancer at a Swiss pediatric hematology-oncology center by means of an online questionnaire. Questions were related to their child’s CAM use over different time intervals, sources of information about CAM use, and communication with the oncologists. RESULTS: Among 140 respondents, CAM was used by 54.3% of patients before diagnosis and 69.3% of patients after diagnosis. During each defined time interval, between 50 and 58.8% of the patients used at least one CAM. Homeopathy was the most popular CAM modality used during oncology treatment, during the first year after treatment, and between 1 and 5 years after the end of treatment. Osteopathy was the most popular CAM ≥5 years after the end of oncology treatment. Forty percent of respondents did not discuss CAM with their oncologist. CONCLUSIONS: The high prevalence of CAM use and the different trends of use during the oncology care pathway and afterward underline the need to increase communication about CAM in the pediatric oncology setting, notably regarding benefits and risks of interaction with oncology treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12906-021-03271-9. BioMed Central 2021-03-18 /pmc/articles/PMC7977159/ /pubmed/33736643 http://dx.doi.org/10.1186/s12906-021-03271-9 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lüthi, Emmanuelle
Diezi, Manuel
Danon, Nadia
Dubois, Julie
Pasquier, Jérôme
Burnand, Bernard
Rodondi, Pierre-Yves
Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
title Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
title_full Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
title_fullStr Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
title_full_unstemmed Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
title_short Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
title_sort complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7977159/
https://www.ncbi.nlm.nih.gov/pubmed/33736643
http://dx.doi.org/10.1186/s12906-021-03271-9
work_keys_str_mv AT luthiemmanuelle complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment
AT diezimanuel complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment
AT danonnadia complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment
AT duboisjulie complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment
AT pasquierjerome complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment
AT burnandbernard complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment
AT rodondipierreyves complementaryandalternativemedicineusebypediatriconcologypatientsbeforeduringandaftertreatment